Related Experiment Video
Updated: Jul 14, 2026

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
Enhancing Pharmaceutical Analysis with Analytical Quality by Design in UHPLC: A Review of Methodological Innovations
1Department of Quality Assurance, Parul Institute of Pharmacy & Research, Parul University, Vadodara, India.
Analytical Quality by Design (AQbD) enhances ultrahigh-performance liquid chromatography (UHPLC) for pharmaceutical analysis. This review consolidates methods for robust, efficient, and regulatory-compliant UHPLC development using risk assessment and optimization strategies.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Science
Background:
- Analytical Quality by Design (AQbD) principles are increasingly adopted in pharmaceutical method development.
- Dedicated reviews focusing on AQbD's application in ultrahigh-performance liquid chromatography (UHPLC) are limited.
- Existing literature primarily covers general AQbD or specific pharmaceutical applications, not UHPLC-focused evaluations.
Purpose of the Study:
- To systematically review and consolidate methods and advancements in AQbD-driven UHPLC for pharmaceutical analysis.
- To bridge the gap in dedicated literature concerning AQbD in UHPLC.
- To provide critical insights for regulatory compliance, lifecycle management, and future UHPLC development.
Main Methods:
- Consolidation of reported methods for risk assessment, experimental design, and optimization in UHPLC.
- Identification of critical method parameters (CMPs) using screening designs (e.g., Plackett-Burman design) and risk assessment tools (e.g., Ishikawa diagrams).
- Optimization of UHPLC performance using response surface methodology (RSM) and examination of factors like stationary phases, mobile phase composition, and flow rates.
Main Results:
- Ethylene-bridged hybrid octadecylsilane columns and water-acetonitrile mobile phases with formic acid or ammonium acetate are frequently reported.
- Gradient elution is common for complex separations, with optimized flow rates (0.2-0.5 mL/min) improving efficiency and sustainability.
- Defined Method Operable Design Regions (MODRs) are established through systematic AQbD approaches.
Conclusions:
- AQbD provides a robust framework for developing and optimizing UHPLC methods in the pharmaceutical industry.
- This review offers a comprehensive overview of AQbD strategies applied to UHPLC, aiding researchers and developers.
- The findings support enhanced regulatory compliance, method lifecycle management, and advancements in pharmaceutical analysis.
More Related Videos
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
Published on: May 20, 2013
06:25Post Column Derivatization Using Reaction Flow High Performance Liquid Chromatography Columns
Published on: April 26, 2016
Related Concept Videos
Development of Analytical Methods
High-Performance Liquid Chromatography: Introduction
In HPLC, two phases play a critical role in the separation process:
High-Performance Liquid Chromatography: Elution Process
High-Performance Liquid Chromatography: Instrumentation
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Biopharmaceutical Factors Influencing Drug Product Design: Overview